Aichholzer, Freyja
Klafki, Hans-Wolfgang
Ogorek, Isabella
Vogelgsang, Jonathan
Wiltfang, Jens
Scherbaum, Norbert
Weggen, Sascha
Wirths, Oliver http://orcid.org/0000-0002-4115-0334
Funding for this research was provided by:
Alzheimer Stiftung Göttingen
ibiMED (UID/BIM/04501/2020)
Article History
Received: 3 February 2021
Accepted: 12 April 2021
First Online: 4 May 2021
Change Date: 30 October 2021
Change Type: Update
Change Details: The paper was amended to add the OA funding note.
Declarations
:
: The collection and archiving of biological samples and clinical data in strictly pseudonymous form in a local biobank and their use in biomarker research were approved by the ethics committee of the University Medical Center Goettingen (9/2/16) and LVR-Hospital Essen (12-5160-BO). Written informed consent was obtained prior to the inclusion in the biobank from all participants or their legal representatives. All procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: All authors gave consent for publication.
: NS received honoraria for several activities (advisory boards, lectures, manuscripts) from AbbVie, Camurus, Hexal, Janssen-Cilag, MSD, Medice, Mundipharma, Reckitt-Benckiser/Indivior, and Sanofi-Aventis. During the last 3 years, he participated in clinical trials financed by the pharmaceutical industry. All other authors declare no competing interests.